Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KMT2A | Q03164 | 3/20 | 0.57 |
| ▸ | MEN1 | O00255 | 1/20 | 0.57 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.55 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.55 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.55 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.49 |
| ▸ | MMP9 | P14780 | 1/20 | 0.48 |
| ▸ | MMP8 | P22894 | 1/20 | 0.48 |
| ▸ | MMP14 | P50281 | 1/20 | 0.48 |
| ▸ | LMNA | P02545 | 3/20 | 0.47 |
| ▸ | SIGMAR1 | Q99720 | 2/20 | 0.47 |
| ▸ | HTT | P42858 | 1/20 | 0.46 |
| ▸ | CASR | P41180 | 2/20 | 0.46 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.46 |
| ▸ | HTR1A | P08908 | 1/20 | 0.46 |
| ▸ | ADRA2A | P08913 | 1/20 | 0.46 |
| ▸ | ADORA3 | P0DMS8 | 1/20 | 0.46 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.46 |
| ▸ | SMPD1 | P17405 | 1/20 | 0.46 |
| ▸ | DRD1 | P21728 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3672190 | 1.00 | KMT2A (0.57) | KMT2AMEN1KDM4EALDH1A1TDP1 | |
| SCHEMBL9674056 | 1.00 | KMT2A (0.57) | KMT2AMEN1KDM4EALDH1A1TDP1 | |
| SCHEMBL29864849 | 1.00 | KMT2A (0.57) | KMT2AMEN1KDM4EALDH1A1TDP1 | |
| SCHEMBL14540134 | 0.83 | CASR (0.70) | KMT2AMEN1KDM4EALDH1A1TDP1 | |
| SCHEMBL15131119 | 0.83 | CASR (0.70) | KMT2AMEN1KDM4EALDH1A1TDP1 | |
| SCHEMBL14099907 | 0.83 | KMT2A (0.50) | KMT2AMEN1KDM4EALDH1A1TDP1 | |
| SCHEMBL1305045 | 0.83 | KMT2A (0.50) | KMT2AMEN1KDM4EALDH1A1TDP1 | |
| SCHEMBL8851088 | 0.82 | BCHE (0.57) | KMT2AKDM4EALDH1A1TDP1SIGMAR1 | |
| SCHEMBL20495654 | 0.82 | KMT2A (0.56) | KMT2AMEN1KDM4EALDH1A1TDP1 | |
| Hydrochloric Acid SCHEMBL11614832 | 0.80 | KMT2A (0.56) | KMT2AMEN1KDM4EALDH1A1TDP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 27 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230137023-A1 | PROCESS FOR PREPARING S-BEFLUBUTAMID BY RESOLVING 2-BROMOBUTANOIC ACID | CHEMINOVA A/S (DK) | 2023-05-04 | — | — | US | claimed |
| US-20230103936-A1 | PREPARATION OF S-BEFLUBUTAMID BY RESOLVING 2-(4-FLUORO-3-(TRIFLUOROMETHYL)PHENOXY)BUTANOIC ACID | CHEMINOVA A/S (DK) | 2023-04-06 | — | — | US | claimed |
| EP-4103544-A1 | PREPARATION OF S-BEFLUBUTAMID BY RESOLVING 2-(4-FLUORO-3-(TRIFLUOROMETHYL)PHENOXY)BUTANOIC ACID | Cheminova A/S (DK) | 2022-12-21 | — | — | EP | claimed |
| EP-4103538-A1 | PROCESS FOR PREPARING S-BEFLUBUTAMID BY RESOLVING 2-BROMOBUTANOIC ACID | Cheminova A/S (DK) | 2022-12-21 | — | — | EP | claimed |
| CN-115103829-A | Method for preparing S-fluorobutachlor by resolving 2-bromobutyric acid | 凯米诺瓦有限公司 | 2022-09-23 | — | — | CN | claimed |
| CN-115087632-A | Preparation of S-fluorobutachlor by resolution of 2- (4-fluoro-3- (trifluoromethyl) phenoxy) butanoic acid | 凯米诺瓦有限公司 | 2022-09-20 | — | — | CN | claimed |
| WO-2021161101-A1 | PREPARATION OF S-BEFLUBUTAMID BY RESOLVING 2-(4-FLUORO-3-(TRIFLUOROMETHYL)PHENOXY)BUTANOIC ACID | CHEMINOVA A/S (DK) | 2021-08-19 | — | — | WO | claimed |
| WO-2021161100-A1 | PROCESS FOR PREPARING S-BEFLUBUTAMID BY RESOLVING 2-BROMOBUTANOIC ACID | CHEMINOVA A/S (DK) | 2021-08-19 | — | — | WO | claimed |
| US-5097043-A | Reaction of 3-acetylthio-2-methylpropionic acid with an optically active benzylamine | E. R. SQUIBB & SONS, INC. (US) | 1992-03-17 | — | — | US | claimed |
| US-5001251-A | Optical resolution of DL-3-acylthio-2-methylpropanoic acid | E. R. SQUIBB & SONS, INC. (US) | 1991-03-19 | — | — | US | claimed |
| US-20230137023-A1 | PROCESS FOR PREPARING S-BEFLUBUTAMID BY RESOLVING 2-BROMOBUTANOIC ACID | CHEMINOVA A/S (DK) | 2023-05-04 | — | — | US | disclosed |
| US-20230137023-A1 | PROCESS FOR PREPARING S-BEFLUBUTAMID BY RESOLVING 2-BROMOBUTANOIC ACID | CHEMINOVA A/S (DK) | 2023-05-04 | — | — | US | disclosed |
| US-20230137023-A1 | PROCESS FOR PREPARING S-BEFLUBUTAMID BY RESOLVING 2-BROMOBUTANOIC ACID | CHEMINOVA A/S (DK) | 2023-05-04 | — | — | US | disclosed |
| US-20230103936-A1 | PREPARATION OF S-BEFLUBUTAMID BY RESOLVING 2-(4-FLUORO-3-(TRIFLUOROMETHYL)PHENOXY)BUTANOIC ACID | CHEMINOVA A/S (DK) | 2023-04-06 | — | — | US | disclosed |
| EP-4103538-A1 | PROCESS FOR PREPARING S-BEFLUBUTAMID BY RESOLVING 2-BROMOBUTANOIC ACID | Cheminova A/S (DK) | 2022-12-21 | — | — | EP | disclosed |
| US-7728177-B2 | Optically active 3-methylcyclopentadecanone and method for producing intermediate thereof | TAKASAGO INTERNATIONAL CORPORATION (JP) | 2010-06-01 | — | — | US | disclosed |
| US-20090124826-A1 | 2-cyclopentadecen-1-one is subjected to a 1,4-conjugate addition reaction of a methyl group by using a methylated organic metal ( dimethylzinc) in presence of a catalyst (trifluoromethanesulfonic acid, cu salt), an enol anion scavenger(propionic anhydride), a specific optically active phosphoramidite | TAKASAGO INTERNATIONAL CORPORATION (JP) | 2009-05-14 | — | — | US | disclosed |
| EP-1884509-A1 | OPTICALLY ACTIVE 3-METHYLCYCLOPENTADECANONE AND METHOD FOR PRODUCING INTERMEDIATE THEREOF | Takasago International Corporation (JP) | 2008-02-06 | — | — | EP | disclosed |
| US-5097043-A | Reaction of 3-acetylthio-2-methylpropionic acid with an optically active benzylamine | E. R. SQUIBB & SONS, INC. (US) | 1992-03-17 | — | — | US | disclosed |
| US-5001251-A | Optical resolution of DL-3-acylthio-2-methylpropanoic acid | E. R. SQUIBB & SONS, INC. (US) | 1991-03-19 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090124826-A1 | 2-cyclopentadecen-1-one is subjected to a 1,4-conjugate addition reaction of a methyl group by using a methylated organic metal ( dimethylzinc) in presence of a catalyst (trifluoromethanesulfonic acid, cu salt), an enol anion scavenger(propionic anhydride), a specific optically active phosphoramidite | CPN1, CAPN1, MCOLN1 | KMT2A 2034/4885MEN1 212/4885KDM4E 2364/4885 |
| US-20230103936-A1 | PREPARATION OF S-BEFLUBUTAMID BY RESOLVING 2-(4-FLUORO-3-(TRIFLUOROMETHYL)PHENOXY)BUTANOIC ACID | RAC2, RAC1, RAC3 | KMT2A 4474/4885MEN1 2294/4885KDM4E 4411/4885 |
| US-20230137023-A1 | PROCESS FOR PREPARING S-BEFLUBUTAMID BY RESOLVING 2-BROMOBUTANOIC ACID | RAC2, RAC1, RAC3 | KMT2A 4178/4885MEN1 1417/4885KDM4E 4516/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.